Qualigen Therapeutics, Inc. announced that it has appointed Shishir Sinha, the company's newly promoted Senior Vice President and current Chief Operating Officer, to lead the company's diagnostics division.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.199 USD | +3.06% | -0.50% | -63.82% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-63.82% | 1.26M | |
+40.80% | 53.67B | |
+34.41% | 38.86B | |
-8.05% | 38.76B | |
-8.98% | 27.27B | |
+10.69% | 25.91B | |
-16.21% | 20.29B | |
+31.00% | 12.78B | |
+28.51% | 12.18B | |
-1.67% | 11.96B |
- Stock Market
- Equities
- QLGN Stock
- News Qualigen Therapeutics, Inc.
- Qualigen Therapeutics Appoints Shishir Sinha to Lead Diagnostics Division Following Promotion to Senior Vice President